secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2026-09-15T20:44:10+00:00
Accession:  0001437749-26-030456
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences signs new $85M ATM equity program with Mizuho, ends TD Cowen ATM
--------------------------------------------------------------------------------

- New equity distribution agreement with Mizuho allows up to $85M in common stock sales; commission up to 3.0%.
- As of Sep 14, 2026, 1.38M shares sold under prior Aug 2026 Mizuho ATM, raising ~$68.8M of $75M limit.
- Terminated TD Cowen distribution agreement with ~$1.0M unsold; effective Sep 14, 2026.
- Sales via at-the-market offerings on Nasdaq under S-3 shelf (File 333-293596) effective Feb 27, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926030456/0001437749-26-030456-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926030456/plse20260914_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-030456

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer